The US Food and Drug Administration (FDA) has approved Vtama® (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...

But people with eczema know another possible explanation for their tell-tale flush: Atopic dermatitis on the face. Here's ...

The US Food and Drug Administration (FDA) has approved Organon’s Vtama (tapinarof) cream, 1% to treat atopic dermatitis in ...

The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the ...

Atopic dermatitis is a chronic condition that requires ... appears at body joints like knees or elbows and even around the neck, but it can occur anywhere on the body. This condition occurs ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

Individuals with atopic dermatitis are at a 1.44% increased risk of developing Meniere disease when compared with those without atopic dermatitis.

Corvus Pharmaceuticals develops next-gen ITK inhibitors, with promising Phase 1 results. Read why CRVS stock can thrive in ...

Patients with lower baseline EASI of head and neck, IgE, or systemic inflammatory ... high response to upadacitinib in patients with atopic dermatitis" DermWorld Weekly; Nov 20, 2024.

The approval was based on data from 2 multicenter, randomized, double-blind, vehicle-controlled trials, ADORING 1 and ADORING 2.

The US Food and Drug Administration (FDA) has approved tapinarof cream, 1% for the treatment of atopic dermatitis (AD) in adults and pediatric patients 2 years of age and older. An aryl ...